APA (7th ed.) Citation

AMA, M., M, S., J, S., AS, K., U, P., & L, A. (2024). Phase to phase: Navigating drug combinations with hypomethylating agents in higher-risk MDS trials for optimal outcomes. Cancer treatment reviews, 123, 102673. https://doi.org/10.1016/j.ctrv.2023.102673

Chicago Style (17th ed.) Citation

AMA, Merz, Sébert M, Sonntag J, Kubasch AS, Platzbecker U, and Adès L. "Phase to Phase: Navigating Drug Combinations with Hypomethylating Agents in Higher-risk MDS Trials for Optimal Outcomes." Cancer Treatment Reviews 123 (2024): 102673. https://doi.org/10.1016/j.ctrv.2023.102673.

MLA (9th ed.) Citation

AMA, Merz, et al. "Phase to Phase: Navigating Drug Combinations with Hypomethylating Agents in Higher-risk MDS Trials for Optimal Outcomes." Cancer Treatment Reviews, vol. 123, 2024, p. 102673, https://doi.org/10.1016/j.ctrv.2023.102673.